Microwave therapy for therapy-resistant plantar warts: A randomized, placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

DRKS

Registry ID

DRKS00030996

Enrollment

Registered

2023-01-20

Start date

2023-02-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B07

Interventions

Group 1: Microwave-Therapy Group 2: Placebo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients aged 18 and over - for a comparable group of patients, the warts should not be larger than 2 cm. - Exclusively plantar warts - The warts should exist for more than 6 months and be pre-treated with at least one method, as an increased rate of spontaneous healing has been described in the first 6 months. - signed consent is available

Exclusion criteria

Exclusion criteria: - Diabetes mellitus - Immune deficiency - Patients with autoimmune diseases - Current cancer - Pacemaker - Incompliance - Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Healing rate of the treated plantar warts	—

Secondary

Measure	Time frame
Painfulness of the therapy	—

Countries

Germany

Contacts

Public ContactSven Krengel

Hautpartner Lübeck/UKSH Lübeck

krengel@hautpartner.de004945181551

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026